RBM-011

N/A

Report date: 2024/12/18 13:39:48

Base Information

Drug NameRBM-011
Drug Alias NameRBM-011
ClassificationBiologics
Mechanisms of ActionInterleukin-21 inhibitors
TargetsInterleukin-21
Therapy Area/IndicationsPulmonary Arterial Hypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRibomic
China Registration ClassN/A

Develop Information

Active CompaniesRibomic
Inactive CompaniesN/A
Active IndicationsPulmonary Arterial Hypertension
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A